BioStem Technologies, Inc.: financial statements

BSEMNASDAQHealthcare · Biological Products, (No Diagnostic Substances)New listingsince Aug 6, 2026

Price

$0.96

November 16, 2026Market cap $18M

New listing: quarterly reports only so far

The first annual report (10-K) is expected around March 31, 2027; valuation and multi-year figures start then.